Company Jiangsu Gdk Biological Technology Co., Ltd

688670

CNE100004NR4

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Annual profits - Rate of surprise

Sector Biopharmaceuticals

JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-07-14 pm EDT			5-day change	1st Jan Change
11.23 ^CNY	-3.93%		-0.62%	-60.54%

Apr. 15	Jiangsu Gdk Biological Technology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Jiangsu Gdk Biological Technology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Jiangsu gdk Biotechnology Co Ltd is a biopharmaceutical company engaged in the research, development, production, and sales of human vaccines. The Companyâs main product is a tetravalent influenza virus split vaccine, which is mainly used to prevent influenza caused by two influenza A virus strains and two influenza B virus strains. The Company's research products also include a variety of human vaccines for the prevention of epidemic colds, rabies, chickenpox, shingles, and pneumonia. The Company distributes its service within the domestic market.

Number of employees: 451

CNY in Million	2022	Weight	2023	Weight	Delta
Quadrivalent Influenza Virus Split Vaccine 100.0 %	318	100.0 %	135	100.0 %	-57.74%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	318	100.0 %	135	100.0 %	-57.74%

Managers	Title	Age	Since
Jian Hui Zhang CEO	Chief Executive Officer	66	23-10-26
Qiang Huang DFI	Director of Finance/CFO	44	21-03-31
Jun Yu CHM	Chairman	55	15-05-31
Jian Guo Xia BRD	Director/Board Member	51	15-05-31
Hua Hai Tan IRC	Investor Relations Contact	44	23-05-09

Members of the board	Title	Age	Since
Rong Shao BRD	Director/Board Member	62	20-06-14
Liang Bin Zhang BRD	Director/Board Member	49	15-05-31
Jian Qiang Guan BRD	Director/Board Member	62	20-06-14
Shen Qian Nie BRD	Director/Board Member	75	15-05-31
Jun Yu CHM	Chairman	55	15-05-31
Jian Guo Xia BRD	Director/Board Member	51	15-05-31
Da Chang Wei CHM	Chairman	55	20-06-14
Ling Huang BRD	Director/Board Member	58	20-06-14
Hui Sheng Yu BRD	Director/Board Member	28	17-01-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	123,200,000	27,807,066 ( 22.57 %)	0	22.57 %

Name	Equities	%	Valuation
Orient Securities Asset Management Co. Ltd. 0.9609 %	412,270	0.9609 %	668 389 ¥
China Asset Management Co., Ltd. 0.7587 %	325,500	0.7587 %	527 714 ¥
Golden Trust Sinopac Fund Management Co., Ltd. 0.3093 %	132,700	0.3093 %	215 139 ¥
Huashang Fund Management Co., Ltd. 0.1169 %	50,158	0.1169 %	81 318 ¥
Cinda Securities Co., Ltd. (Investment Management) 0.0699 %	30,000	0.0699 %	48 637 ¥
Manulife TEDA Fund Management Co., Ltd. 0.0471 %	20,200	0.0471 %	32 749 ¥
Oriental Alpha Fund Management Co. Ltd. 0.0216 %	9,287	0.0216 %	15 056 ¥
HFT Investment Management Co., Ltd. 0.0198 %	8,500	0.0198 %	13 781 ¥
Bosera Asset Management Co., Ltd. 0.0116 %	4,979	0.0116 %	8 072 ¥
Yinhua Fund Management Co., Ltd. 0.007195 %	3,087	0.007195 %	5 005 ¥

Jiangsu gdk Biotechnology Co., Ltd.

12 Yujin Road

225300, Taizhou

http://www.gdkbio.com

address Jiangsu Gdk Biological Technology Co., Ltd(688670)

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

11.23

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
JIANGSU GDK BIOLOGICAL TECHNOLOGY CO., LTD	-60.54%	199M
CSL LIMITED	+7.64%	101B
SAMSUNG BIOLOGICS CO.,LTD.	+7.76%	42.63B
BIOGEN INC.	-14.37%	33.5B
UCB	+82.32%	29.77B
BIOMARIN PHARMACEUTICAL INC.	-12.27%	16.14B
INCYTE CORPORATION	+2.33%	14.31B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-8.56%	11.55B
ALTEOGEN INC.	+182.74%	10.53B
SWEDISH ORPHAN BIOVITRUM AB	+3.67%	9.2B

Biopharmaceuticals